-
-
Intranasal administration of recombinant human cartilage glycoprotein-39 as a treatment for rheumatoid arthritis: a phase II, multicentre, double-blind, randomised, placebo-controlled, parallel-group, dose-finding trial
-
-
Antibodies against p53 are associated with poor prognosis of colorectal cancer
-
-
P53, a potential target for tumor-directed cells
-
-
Characterization of Cytotoxic T Lymphocyte Epitopes of a Self-Protein, p53, and a Non-Self-Protein, Influenza Matrix: Relationship between Major Hhistocomptability Complex Peptide Binding Affinity and Immune Responsiveness to Peptides
-
-
In vitro induction of huan cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53*
-
-
Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes